Product Alert – Daprodustat
Daprodustat is a potent reversible inhibitor of hypoxia-inducible factor (HIF)-prolyl hydroxylase (PH) 1, PH2 and PH3, with an IC50 in the low nM range. By inhibiting HIF-PHDs, Daprodustat promotes the stabilisation and nuclear accumulation of HIF-1α and HIF-2α transcription factors.
Dr. Reddy's API Offering*
Targeting CS01 form - Lab samples and COA are available.
- Reliable KSM suppliers were added to ensure timely deliveries and adherence to stringent specifications.
- We are planning adequate capacity to supply development quantity in a short lead time.
- cGMP API manufacturing facilities, successfully inspected by TGA, WHO GMP, KFDA, PMDA, Health Canada, ANVISA & USFDA.
- Planning USDMF by December 2024.
To learn more about our API offerings, please read the Tech sheet on Daprodustat API by filling out the contact form below.
Note: *Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale.
Explore other Whitepapers:
Know More- Email us: api@drreddys.com
-
+91 40 49002222
Download Now
Complete el formulario de contacto a continuación para ver el documento técnico